Unilever Earnings Calls
| Release date | Feb 12, 2026 |
| EPS estimate | $1.75 |
| EPS actual | $1.37 |
| EPS Surprise | -21.71% |
| Revenue estimate | 31.394B |
| Revenue actual | 29.709B |
| Revenue Surprise | -5.37% |
| Release date | Jul 31, 2025 |
| EPS estimate | $1.83 |
| EPS actual | $1.67 |
| EPS Surprise | -8.74% |
| Revenue estimate | 34.487B |
| Revenue actual | 35.473B |
| Revenue Surprise | 2.86% |
| Release date | May 01, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Feb 13, 2025 |
| EPS estimate | $1.53 |
| EPS actual | $0.85 |
| EPS Surprise | -44.77% |
| Revenue estimate | 31.627B |
| Revenue actual | 30.696B |
| Revenue Surprise | -2.94% |
Last 4 Quarters for Unilever
Below you can see how UL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 13, 2025 |
| Price on release | $70.90 |
| EPS estimate | $1.53 |
| EPS actual | $0.85 |
| EPS surprise | -44.77% |
| Date | Price |
|---|---|
| Feb 07, 2025 | $73.82 |
| Feb 10, 2025 | $73.81 |
| Feb 11, 2025 | $74.65 |
| Feb 12, 2025 | $74.92 |
| Feb 13, 2025 | $70.90 |
| Feb 14, 2025 | $69.54 |
| Feb 18, 2025 | $69.58 |
| Feb 19, 2025 | $70.49 |
| Feb 20, 2025 | $70.36 |
| 4 days before | -3.96% |
| 4 days after | -0.751% |
| On release day | -1.91% |
| Change in period | -4.69% |
| Release date | May 01, 2025 |
| Price on release | $79.80 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 25, 2025 | $79.33 |
| Apr 28, 2025 | $80.04 |
| Apr 29, 2025 | $79.99 |
| Apr 30, 2025 | $80.51 |
| May 01, 2025 | $79.80 |
| May 02, 2025 | $80.45 |
| May 05, 2025 | $80.41 |
| May 06, 2025 | $80.95 |
| May 07, 2025 | $81.22 |
| 4 days before | 0.591% |
| 4 days after | 1.78% |
| On release day | 0.81% |
| Change in period | 2.38% |
| Release date | Jul 31, 2025 |
| Price on release | $74.02 |
| EPS estimate | $1.83 |
| EPS actual | $1.67 |
| EPS surprise | -8.74% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $76.56 |
| Jul 28, 2025 | $75.01 |
| Jul 29, 2025 | $75.16 |
| Jul 30, 2025 | $74.76 |
| Jul 31, 2025 | $74.02 |
| Aug 01, 2025 | $76.61 |
| Aug 04, 2025 | $76.23 |
| Aug 05, 2025 | $76.18 |
| Aug 06, 2025 | $77.04 |
| 4 days before | -3.31% |
| 4 days after | 4.07% |
| On release day | 3.49% |
| Change in period | 0.629% |
| Release date | Feb 12, 2026 |
| Price on release | $73.46 |
| EPS estimate | $1.75 |
| EPS actual | $1.37 |
| EPS surprise | -21.71% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $72.12 |
| Feb 09, 2026 | $71.36 |
| Feb 10, 2026 | $71.97 |
| Feb 11, 2026 | $73.27 |
| Feb 12, 2026 | $73.46 |
| Feb 13, 2026 | $74.59 |
| Feb 17, 2026 | $73.96 |
| Feb 18, 2026 | $72.42 |
| Feb 19, 2026 | $72.01 |
| 4 days before | 1.86% |
| 4 days after | -1.97% |
| On release day | 1.54% |
| Change in period | -0.153% |
Unilever Earnings Call Transcript Summary of Q4 2025
Unilever delivered a solid 2025 in line with guidance despite a tough macro and significant currency headwinds. Underlying sales growth was 3.5% (volumes +1.5%, price +2%), with Power Brands (78% of revenue) outperforming the group. The company completed the Ice Cream demerger and rotated ~15% of the portfolio via 10 transactions, sharpening focus on Beauty & Wellbeing and Personal Care and prioritizing premium, digitally-native and e‑commerce-led brands (notable acquisitions: Minimalist, Wild, Dr. Squatch). Gross margin expanded for the third consecutive year and underlying operating margin rose 60 bps to 20%. Underlying EPS was EUR 3.08 (+0.7% reported; +9.5% constant currency). Free cash flow was EUR 5.9bn (100% conversion) and net debt fell to EUR 23.1bn; net debt/EBITDA ~2x. Productivity savings of ~EUR 670m have been delivered so far, with a target of EUR 800m by 2026. Brand & marketing spend increased to 16.1% of turnover (highest in a decade), with 100% of incremental investment behind Power Brands. Guidance for 2026: underlying sales growth at the low end of the multi‑year 4–6% range, volume growth of at least 2%, modest further margin improvement, and a new EUR 1.5bn share buyback; continued focus on volume-led growth, mix improvement and gross margin expansion. Key regional notes: North America remains a standout growth engine; emerging markets improved through the year (notably India, Indonesia, parts of Asia) though Latin America remains challenging but showed signs of recovery in Q4. Capital allocation priorities remain growth/productivity, portfolio reshaping, and attractive capital returns.
Sign In
Buy UL